Foster & Motley Inc. Invests $1.19 Million in Cabot Corporation $CBT

Foster & Motley Inc. acquired a new position in shares of Cabot Corporation (NYSE:CBT) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 13,152 shares of the specialty chemicals company’s stock, valued at approximately $1,194,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. BlackRock Inc. acquired a new position in shares of Cabot during the second quarter worth approximately $633,302,000. Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Cabot by 5.6% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after acquiring an additional 124,613 shares in the last quarter. State Street Corp lifted its holdings in Cabot by 1.0% during the 4th quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after buying an additional 20,021 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Cabot by 4.8% during the first quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock worth $131,253,000 after buying an additional 79,499 shares during the last quarter. Finally, Bank of America Corp DE grew its position in shares of Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after buying an additional 63,080 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Cabot

In other news, CEO Sean D. Keohane sold 91,923 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,921,218.94. This represents a 18.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 3.08% of the stock is currently owned by insiders.

Cabot Stock Performance

Shares of CBT stock opened at $85.34 on Thursday. The stock has a market capitalization of $4.41 billion, a PE ratio of 24.04, a PEG ratio of 10.99 and a beta of 0.84. The business’s 50 day simple moving average is $88.23 and its 200 day simple moving average is $80.75. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53.

Cabot (NYSE:CBT) last issued its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, research analysts forecast that Cabot Corporation will post 6.33 earnings per share for the current year.

Cabot Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. Cabot’s dividend payout ratio (DPR) is 53.24%.

Wall Street Analyst Weigh In

CBT has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Mizuho upped their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. UBS Group reduced their price target on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $89.00.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.